Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Suppan Christoph |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2023
Originalarbeit (Zeitschrift)
** Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Solkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
EUR J CANCER. 2023; 180: 108-116.
Doi: 10.1016/j.ejca.2022.12.003
Web of Science
PubMed
FullText
FullText_MUG
** Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1):
Doi: 10.3390/ijms24010818
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Suppan, C; Balic, M
Current standards and future outlooks in metastatic Her2-positive breast cancer
BREAST CARE. 2023;
Doi: 10.1159/000528756
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stöger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel). 2022; 17(2):137-145
Doi: 10.1159/000516157
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grunberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
WIEN KLIN WOCHENSCHR. 2022;
Doi: 10.1007/s00508-022-02082-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463
Doi: 10.1038/s41416-021-01601-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stöger, H; Greil, R
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel). 2022; 17(1): 1-9.
Doi: 10.1159/000512467
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Editorial
** Suppan, C
ESMO 2021-my top three abstracts in breast cancer
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00810-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rezension
** Balic, M; Wimmer, K; Suppan, C; Silovski, T; Brunner, C
Expert Discussion: ASCO 2022
BREAST CARE. 2022; 17(4): 430-436.
Doi: 10.1159/000525966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400
Doi: 10.1002/1878-0261.12870
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stoger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
BREAST CARE. 2021;
Doi: 10.1159/000516157
Web of Science
FullText
FullText_MUG
** Gnant, M; Fitzal, F; Rinnerthaler, G; Steger, GG; Greil-Ressler, S; Balic, M; Heck, D; Jakesz, R; Thaler, J; Egle, D; Manfreda, D; Bjelic-Radisic, V; Wieder, U; Singer, CF; Melbinger-Zeinitzer, E; Haslbauer, F; Sevelda, P; Trapl, H; Wette, V; Wimmer, K; Gampenrieder, SP; Bartsch, R; Kacerovsky-Strobl, S; Suppan, C; Brunner, C; Deutschmann, C; Soelkner, L; Fesl, C; Greil, R, , Austrian, Breast, and, Colorectal, Cancer, Study, Group;Austrian, Breast, and, Colorectal, Cancer, Study, Group
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med. 2021; 385(5):395-405
Doi: 10.1056/NEJMoa2104162
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Posch, F; Mueller, HD; Mischitz, N; Steiner, D; Klocker, EV; Setaffy, L; Bargfrieder, U; Hammer, R; Hauser, H; Jost, PJ; Dandachi, N; Lax, S; Balic, M
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Cancers (Basel). 2021; 13(10):
Doi: 10.3390/cancers13102492
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Steiner, D; Klocker, EV; Posch, F; Henzinger, E; Muller, HD; Stoger, H; Dandachi, N; Balic, M
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
BREAST CARE. 2021;
Doi: 10.1159/000513766
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)
BREAST CARE. 2021;
Doi: 10.1159/000512467
Web of Science
FullText
FullText_MUG
Kurzbericht/Letter
** Suppan, C
Post San Antonio update-my top three abstracts!
MEMO-MAG EUR MED ONC. 2021;
Doi: 10.1007/s12254-021-00718-0
Web of Science
FullText
FullText_MUG
Abstract (Zeitschrift)
** Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, AL; Suppan, C; Heibl, S; Voskova, D; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Andel, J; Hubalek, M; Knauer, M; Greil, R
Does complete surgical removal of metastases in oligometastatic breast cancer improve survival? A matched-pair analysis of the AGMT_MBC-registry
CANCER RES. 2021; 81(4):
[Poster]
Web of Science
** Rinnerthaler, G; Gampenrieder, SP; Tinchon, C; Petzer, AL; Suppan, C; Heibl, S; Voskova, D; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Andel, J; Hubalek, M; Knauer, M; Greil, R
First-line treatment of hormone receptor positive metastatic breast cancer (MBC) in everyday practice: Results from the Austrian AGMT_MBC-Registry
CANCER RES. 2021; 81(4):
[Poster]
Web of Science
** Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M
Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4):
[Poster]
Web of Science
2020
Kurzbericht/Letter
** Suppan, C; Balic, M
Treatment options in early triple-negative breast cancer Update from the San Antonio Breast Cancer Symposium 2019.
MEMO-MAG EUR MED ONC. 2020;
Doi: 10.1007/s12254-020-00609-w
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Übersichtsarbeit
** Klocker, EV; Suppan, C
Biomarkers in Her2-Positive Disease.
BREAST CARE. 2020; 15(6): 586-593.
Doi: 10.1159/000512283
Web of Science
FullText
FullText_MUG
Editorial
** Suppan, C; Balic, M
It is time to prepare for D-CARE!
ANN TRANSL MED. 2020; 8(21): 1339
Doi: 10.21037/atm-2020-99
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Singer, CF; Egle, D; Greil, R; Ohler, L; Petru, E; Suppan, C; Marhold, M; Pfeiler, G; Brunner, C; Tinchon, C; Halper, S; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Hennebelle, M; Mraz, B; Bartsch, R
REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC).
ANN ONCOL. 2020; 31: S77-S78.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.272
[Oral Communication]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M
Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15):
[Onlinepräsentation]
Web of Science
FullText
** Suppan, C; Zhou, Q; Graf, R; Klocker, V; Terbuch, A; Dandachi, N; Heitzer, E; Balic, M
Liquid biopsy-based detection of PIK3Ca mutations in HR positive metastastic breast cancer patients.
ANN ONCOL. 2020; 31: S41-S41.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.213
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Čipak Gašparović, A; Milković, L; Dandachi, N; Stanzer, S; Pezdirc, I; Vrančić, J; Šitić, S; Suppan, C; Balic, M
Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.
Antioxidants (Basel). 2019; 8(12): 633
Doi: 10.3390/antiox8120633
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Müller, HD; Posch, F; Suppan, C; Bargfrieder, U; Gumpoldsberger, M; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoeger, H; Lax, S; Balic, M
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Ann Surg Oncol. 2019; 26(13):4274-4283
Doi: 10.1245/s10434-019-07741-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M
Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8):
Doi: 10.3390/cancers11081171
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Suppan, C; Balic, M
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer The best of ASCO 2019
MEMO-MAG EUR MED ONC. 2019;
Doi: 10.1007/s12254-019-00530-x
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Abstract (Zeitschrift)
** Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N
Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
** Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M
Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41.
[Poster]
Web of Science
2018
Abstract (Zeitschrift)
** Balic, M; Mueller, DH; Hammer, R; Gumpoldsberger, M; Suppan, C; Posch, F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S
Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Poster]
Web of Science
** Muller, HD; Posch, F; Gumpoldsberger, M; Suppan, C; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoger, H; Lax, S; Balic, M
Prognostic impact of the Residual Cancer Burden (RCB) index on recurrence-free survival of breast cancer patients recieving neoadjuvant therapy
ONCOL RES TREAT. 2018; 41: 297-298.
[Poster]
Web of Science
** Suppan, C; Brcic, I; Heitzer, E; Tiran, V; Mueller, HD; Auer, M; Cote, RJ; Datar, R; Dandachi, N; Balic, M
Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment
EUR J CANCER. 2018; 92: S136-S136.-11th European Breast Cancer Conference (EBCC); MAR 21-23, 2018; Barcelona, SPAIN.
[Poster]
Web of Science
2017
Originalarbeit (Zeitschrift)
** Benezeder, T; Tiran, V; Treitler, AAN; Suppan, C; Rossmann, C; Stoeger, H; Cote, RJ; Datar, RH; Balic, M; Dandachi, N
Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.
Oncotarget. 2017; 8(54):92483-92496
Doi: 10.18632/oncotarget.21426
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Suppan, C; Balic, M
Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.
Memo. 2017; 10(2):82-85
Doi: 10.1007/s12254-017-0328-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Suppan, C; Tiran, V; Heitzer, E; Auer, M; Cote, RJ; Datar, RH; Dandachi, N; Balic, M
Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis
EUR J CANCER. 2017; 72: S39-S40.
Doi: 10.1016/S0959-8049(17)30211-3
[Poster]
Web of Science
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Suppan, C; Bjelic-Radisic, V; La Garde, M; Groselj-Strele, A; Eberhard, K; Samonigg, H; Loibner, H; Dandachi, N; Balic, M
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
BMC Cancer. 2015; 15:1027-1027
Doi: 10.1186/s12885-015-2005-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Kump, P; Suppan, C; Spindelbock, W; Krejs, G; Lipp, R
Fifty-Three Year-Old-Male with a Symptomatic Ileocecal Carcinoid: An Individual Follow-Up of 14 Yrs with 5 Different Anti-Proliferative Therapies
NEUROENDOCRINOLOGY. 2015; 102(1-2):151-151.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
2014
Abstract (Zeitschrift)
** Suppan, C; Bjelic-Radisic, V; La Garde, M; Samonigg, H; Dandachi, N; Balic, M
N/L Ratio does not have predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
EUR J CANCER. 2014; 50: S193-S193.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
[Poster]
Web of Science
** Suppan, C; Milkovic, L; Gasparovic, AC; Samonigg, H; Dandachi, N; Balic, M
Higher levels of HNE are associated with disease aggressiveness and worse outcome in breast cancer patients
EUR J CANCER. 2014; 50: S70-S70.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
[Poster]
Web of Science
2013
Abstract (Zeitschrift)
** Suppan, C; Bjelic-Radisic, V; La Guarde, M; Dandachi, N; Balic, M
Neutrophil/Lymphocyte Ratio does not have predictive or prognostic value in breast cancer patients undergoing neoadjuvant systemic therapy
ONKOLOGIE. 2013; 36: 158-158.
[Poster]
Web of Science
** Suppan, C; Milkovic, L; Gasparovic, AC; Waeg, G; Dandachi, N; Balic, M
Higher levels of HNE are associated with disease aggressiveness and worse outcome of breast cancer patients
ONKOLOGIE. 2013; 36: 176-176.
Web of Science